diphenyl-1-pyrenylphosphine has been researched along with nadp in 1 studies
Studies (diphenyl-1-pyrenylphosphine) | Trials (diphenyl-1-pyrenylphosphine) | Recent Studies (post-2010) (diphenyl-1-pyrenylphosphine) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
22 | 1 | 7 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, JW; Yang, JH | 1 |
1 other study(ies) available for diphenyl-1-pyrenylphosphine and nadp
Article | Year |
---|---|
Oxalomalate, a competitive inhibitor of NADP+-dependent isocitrate dehydrogenase, enhances lipid peroxidation-mediated oxidative damage in U937 cells.
Topics: Amidines; Cells, Cultured; Enzyme Inhibitors; Glutathione; Humans; Isocitrate Dehydrogenase; Lipid Peroxidation; Malondialdehyde; Microscopy, Confocal; NADP; Organophosphorus Compounds; Oxalates; Oxidants; Oxidation-Reduction; Oxidative Stress; Pyrenes; U937 Cells | 2003 |